Metalmark Capital has completed a majority investment in Bostwick Laboratories. The company, which was advised by McColl Partners, provides urologic anatomic pathology laboratory services and specializes in the monitoring and diagnosis of cancer. The new capital will help the company pursue its growth initiatives and expand development of its services.
